Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
Lilly Needs a Plan to Spur Weight-Loss Drug Sales, Investors Say
Lilly Chief Financial Officer Lucas Montarce told Reuters last month the drugmaker is trying to balance its demand-generation activities with its ability to supply more patients. The company last year ...
ALS News Today5d
Radicava delays time to certain ALS disease progression milestones
In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched controls who hadn't.
W magazine8d
Rick Owens’s Favorite $30 Toothpaste Is Actually Fantastic
The designer's go-to oral-care brand offers elevated mouthwash and "oral extract water," a chewing gum alternative.
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
sicklecellanemianews11d
Companies partner to develop oral treatments for SCD, other diseases
Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other ...
Weight-Loss Drug Developer Metsera Targets up to $1.78 Billion Valuation in US IPO
(Reuters) -Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in ...
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
C&EN17d
Reactive Oxygen Species-Responsive Gel-Based Microneedle Patches with Antimicrobial and Immunomodulating Properties for Oral Mucosa Disease Treatment
Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou 646000, China ...
CNN17d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment ... not respond to oral antidepressants ...
verywellhealth18d
Gluten-Free Medications for Diarrhea, Constipation, and Heartburn
The Food and Drug Administration notes that most oral medications do not contain gluten. Anti-diarrhea medications, laxatives, and gluten-free antacids are available over-the-counter (OTC), but not ...